InspireMD Inc. (NSPR) earnings
NSPR earnings moved a median of -1.57% by the close. Quarterly and annual NSPR reports and results, each read against the price at its own news timestamp. Back to the NSPR overview →
29 measured NSPR earnings events.
Where these NSPR earnings landedvs 29 measured NSPR earnings reactions
| Middle 50% of NSPR earnings reactions | -7.16% to +0.87% |
|---|---|
| Median reaction (to close) | -1.57% |
| Measured reactions | 29 |
Point-in-time · zero look-ahead
Half of the 29 NSPR earnings events with a measured close landed between -7.16% and +0.87%; 28% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| InspireMD Reports Second Quarter 2026 Financial Results | Press release | -8.06% | -7.16% | |
| Form 10-Q InspireMD, Inc. For: Jun 30 | SEC filing · Form 10-Q | -8.06% | -7.16% | |
| Form 10-Q InspireMD, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.30% | +0.87% | |
| InspireMD Reports First Quarter 2026 Financial Results | Press release | +9.80% | +7.84% | |
| InspireMD to Announce First Quarter 2026 Financial Results | Press release | +0.00% | -5.79% | |
| Form 10-K InspireMD, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.77% | -9.60% | |
| Form 10-Q InspireMD, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.21% | -3.55% | |
| InspireMD Reports Third Quarter 2025 Financial Results | Press release | -2.55% | -11.46% | |
| InspireMD to Announce Third Quarter 2025 Financial Results | Press release | +0.00% | -4.68% | |
| InspireMD Reports Second Quarter 2025 Financial Results | Press release | -1.67% | -9.26% | |
| Form 10-Q InspireMD, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.67% | -9.26% | |
| InspireMD to Announce Second Quarter 2025 Financial Results | Press release | +0.98% | -1.57% | |
| InspireMD Reports First Quarter 2025 Financial Results | Press release | -1.92% | +0.00% | |
| Form 10-Q InspireMD, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.92% | +0.00% | |
| InspireMD to Announce First Quarter 2025 Financial Results | Press release | +0.00% | -0.39% | |
| Form 10-K InspireMD, Inc. For: Dec 31 | SEC filing · Form 10-K | -15.67% | -15.87% | |
| Form 10-Q InspireMD, Inc. For: Sep 30 | SEC filing · Form 10-Q | +3.12% | +10.41% | |
| InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update | Press release | +4.35% | +15.22% | |
| InspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12th | Press release | — | +0.00% | |
| InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update | Press release | +0.00% | +3.45% | |
| Form 10-Q InspireMD, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +3.45% | |
| InspireMD to Report Second Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, August 6th | Press release | +0.00% | -18.82% | |
| InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update | Press release | -1.85% | -1.98% | |
| Form 10-Q InspireMD, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.85% | -1.98% | |
| InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, May 14th | Press release | -6.50% | +1.44% | |
| Form 10-K InspireMD, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -1.17% | |
| Form 10-Q InspireMD, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| InspireMD Reports Third Quarter 2023 Financial Results and Provides Business Update | Press release | +5.26% | +3.41% | |
| InspireMD to Report Third Quarter 2023 Financial Results and Provide Corporate Business Update on Monday, November 6th | Press release | +0.99% | -4.67% |
Keep exploring
More NSPR: analyst actions → · SEC filings → · NSPR overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Solana Company - Class A (HSDT) | 272 | -1.20% | 37% |
| PRECISION OPTICS CORP NEW (PEYE) | 272 | 0.00% | 24% |
| Osmotica Pharmaceuticals plc - Ordinary Shares (OSMT) | 271 | -0.69% | 33% |
| Sutro Biopharma, Inc. (STRO) | 271 | -0.56% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.